Best Telehealth Providers for Wegovy in 2026
Compare reviewed GLP-1 weight loss providers, billing commitments, and the treatments their links actually offer.
We may earn a commission through provider links. Matching affiliate offers and editorial priorities affect inclusion and suggested order in commercial guides. Scores are not clinical endorsements. Disclosure · Methodology
Compare the options first
Full comparison & price terms ↓A short preview in editorial order—not a guarantee of the cheapest total bill. Read the commitment terms before choosing.
The Ranking
SkinnyRx
Clinician-guided GLP-1 platform with both compounded and brand-name access plus overnight shipping.
Editor’s take: Premium positioning, premium catalog. If you want maximum optionality across GLP-1 modalities, this is the deepest menu on the site. The premium catalog comes at a premium price. If you want maximum optionality across GLP-1 modalities, SkinnyRx is the deepest menu on the site; if you want the lowest cost, look at Trimi or HealthRx.
Full review →
Shed Rx
GLP-1 clinic offering injections, oral semaglutide, drops, and lozenges plus brand-name Wegovy and Zepbound.
Editor’s take: A reasonable mid-priced pick when delivery flexibility matters. Verify auto-billing terms before signing up given mixed reports. Verify auto-billing terms before signing up given mixed reviews on cancellation. If delivery flexibility is your priority, compare ShedRx against Breeze Meds which also offers sublingual tirzepatide.
Full review →
FuturHealth
GLP-1 weight-loss platform combined with personalised nutrition and fitness coaching.
Editor’s take: Coaching is the differentiator. If you're going to use it, FuturHealth pulls ahead of cheaper, drug-only competitors. If you won't, save the money.
Full review →
Found
GLP-1 platform that pairs medication with one-on-one coaching and a broad off-label formulary.
Editor’s take: One of the more coaching-forward GLP-1 telehealth options. Pricing tiers can confuse first-time buyers; verify the cancellation terms before subscribing. Pricing tiers can confuse first-time buyers; verify the cancellation policy before subscribing. If you want the lowest possible cost for compounded GLP-1 without coaching, Trimi or HealthRx will be significantly cheaper.
Full review →
Strut Health
Broad-catalog telehealth covering hair, skin, weight loss, and sexual health, with free shipping and follow-ups bundled in.
Editor’s take: An efficient generalist. If you want depth in any one category, you'll find better. If you want breadth and a low management overhead, Strut Health is on the shortlist.
Full review →
Zealthy
Online GLP-1 care centered on insurance navigation, brand-name prescriptions and cash-pay semaglutide options.
Editor’s take: Zealthy pairs online weight-management care with insurance-navigation support and a cash-pay path. Its displayed $25–$151 monthly range is useful for comparison, but the endpoints carry different insurance and commitment conditions; confirm the exact medication, covered benefit, recurring fee, dose and renewal terms before paying.
Full review →
FeelGood
Personalized GLP-1 program with injectable and oral options, 24/7 clinician support, and a money-back guarantee from $149/mo.
Editor’s take: A well-rounded compounded GLP-1 program with one of the most comprehensive support offerings in the category. The 24/7 unlimited support and money-back guarantee stand out. Oral tablet option is a plus for needle-averse patients.
Full review →
AltRx
Budget-first compounded GLP-1 clinic with a low advertised entry price ($89/mo semaglutide), transparent pricing, and optional brand-name GLP-1 access.
Editor’s take: A competitive budget-tier GLP-1 option with a low promotional entry price. Readers should note that the $89/mo rate is a first-month promotional price; standard pricing starts at $159/mo. The BNPL option and brand-name access add flexibility.
Full review →2026 Price Comparison. Published Price Terms
Compare the lower and higher listed rates, then read the billing conditions. A listed monthly equivalent may require prepayment; visits, medication, membership, or shipping can cost extra.
Recorded price-check dates: 17 June 2026. Per-provider dates below; these are not a guarantee of today's checkout price.
Rates use different billing terms and are not necessarily all-in or month-to-month. Confirm total charges and cancellation terms. Compounded medications are not FDA-approved finished drugs; pharmacy type alone does not establish legality or clinical suitability.
4 providers · Trustpilot scores are customer opinions, not treatment results.
| Provider & billing terms | Lower listed rate | Higher listed rate | Pharmacy | Reviews & price check | Actions |
|---|---|---|---|---|---|
| SkinnyRxBest Overall | Lower listed rate$149/mo | Higher listed rate$249/mo | PharmacyBrand Rx | 4.8/5 5,335 reviews 17 June 2026 | Go SkinnyRxRead full review |
| Found Health | Lower listed rate$129/mo | Higher listed rate$349/mo | PharmacyBrand Rx | 3.7/5 729 reviews 17 June 2026 | Go FoundRead full review |
| FeelGood | Lower listed rate$149/mo | Higher listed rate$349/mo | PharmacyBrand Rx | 4.5/5 17 June 2026 | Go FeelGoodRead full review |
| Shed Rx | Lower listed rate$199/mo | Higher listed rate$449/mo | PharmacyBrand Rx | 4.7/5 956 reviews 17 June 2026 | Go Shed RxRead full review |
Provider links may earn a commission. Rate sorting compares the displayed numbers, not equivalent treatment plans or total commitments. How we check price terms →
What to know before choosing
Wegovy (semaglutide 2.4 mg, Novo Nordisk) is the FDA-approved injectable GLP-1 for chronic weight management. In the pivotal STEP 1 trial (NEJM 2021), participants lost a mean of 14.9% of body weight at 68 weeks. Several telehealth platforms now prescribe it without requiring an in-person visit. We compared the platforms that carry brand-name Wegovy on formulary, not compounded semaglutide. On pricing, insurance navigation, clinical oversight, and shipping reliability.
Wegovy (semaglutide 2.4 mg) is the FDA-approved injectable GLP-1 for chronic weight management, with the strongest long-term efficacy and cardiovascular outcomes data in the class. The STEP 1 trial (NEJM 2021) showed 14.9% mean weight loss at 68 weeks; the SELECT trial (NEJM 2023) demonstrated a 20% reduction in major adverse cardiovascular events in adults with obesity and established cardiovascular disease.
Accessing brand-name Wegovy through telehealth requires a licensed prescriber and a pharmacy that stocks it — which is not universal. List price without insurance is approximately $1,350/month. The best telehealth platforms that prescribe Wegovy have a clear insurance navigation pathway, offer manufacturer savings programmes (Novo Nordisk's WeGoTogether programme), and include a licensed physician in the prescribing workflow.
We evaluated the platforms in our network that actively prescribe brand-name Wegovy (not compounded semaglutide) and ranked them on prescribing access, insurance navigation support, pricing transparency, and clinical oversight quality.
Methodology
Only platforms that prescribe FDA-approved Wegovy (not compounded semaglutide) are included. Ranked on pricing transparency, insurance support, clinical oversight quality, and Trustpilot score.
Getting Wegovy Through Telehealth: What to Expect
Wegovy (semaglutide 2.4 mg) is the first GLP-1 medication FDA-approved specifically for chronic weight management in adults without diabetes. Getting it through telehealth is straightforward if you know what to expect — and what the real costs are.
Wegovy vs Ozempic: Same Molecule, Different Approval
Wegovy and Ozempic both contain semaglutide. The difference is the approved dose and indication: Ozempic is approved for type 2 diabetes at doses up to 2 mg; Wegovy is approved for chronic weight management at 2.4 mg. The titration schedule is also different — Wegovy titrates more slowly to reduce GI side effects.
Prescribing Ozempic off-label for weight loss is common but creates insurance complications (most plans cover Ozempic for diabetes, not weight loss). Telehealth clinics that prescribe Wegovy specifically are targeting the approved weight management indication, which is the cleaner pathway for non-diabetic patients.
Insurance Coverage and Real Costs
Wegovy is covered by an increasing number of commercial insurance plans, particularly since the 2024 CMS announcement that Medicare Advantage plans can cover it for cardiovascular risk reduction (following the SELECT trial). Medicaid coverage varies by state. The list price without insurance is approximately $1,350/month.
Novo Nordisk's WeGoSupport savings program can reduce out-of-pocket costs to $0/month for commercially insured patients and $25/month for uninsured patients who meet income criteria. Telehealth clinics that help patients navigate insurance and savings programs are providing meaningful value beyond the prescription.
What to Expect Clinically
Wegovy is titrated over 16 weeks from 0.25 mg to the 2.4 mg maintenance dose. The titration period is designed to minimize GI side effects — nausea, vomiting, diarrhea — which are most common during dose escalation. Most patients tolerate the maintenance dose well after the titration period.
Weight loss typically begins in the first month and continues through the titration period. The STEP 1 trial showed a mean weight loss of 14.9% over 68 weeks. Individual results vary significantly — some patients lose 20%+, others lose less than 10%. Factors that predict better response include higher baseline BMI, consistent titration, and behavioral support.
Wegovy through telehealth is a legitimate, evidence-based pathway for weight management. The clinics in our top tier above help with insurance navigation, provide proper titration support, and offer clinician access throughout the program.
What the Studies Actually Show
Wegovy contains semaglutide 2.4 mg, the same active ingredient studied in the STEP programme. The figures below are from the pivotal STEP 1 trial and the SELECT cardiovascular outcomes trial.
| Endpoint | Finding |
|---|---|
| Mean weight loss (STEP 1, 68 weeks, 2.4 mg)1 | −14.9% body weight vs −2.4% placebo in adults with overweight/obesity without diabetes |
| Cardiovascular outcomes (SELECT, ~40 months)2 | 20% relative risk reduction in major adverse cardiovascular events (MACE) in adults with established CV disease and overweight/obesity |
| GI side effects (FDA prescribing information)3 | Nausea ≥10%, diarrhea ≥10%, vomiting ≥10%, constipation ≥10%; most cases mild–moderate and dose-dependent |
| Boxed warning3 | Risk of thyroid C-cell tumors observed in rodent studies; contraindicated in personal/family history of MTC or MEN 2 |
Frequently Asked Questions
How much does Wegovy cost through telehealth?
Without insurance, Wegovy typically costs $1,300-$1,700 per month at retail. Most telehealth platforms that prescribe it offer insurance navigation or prior-authorisation support. With commercial insurance or a Novo Nordisk savings card, out-of-pocket costs can drop to $25-$200/month for eligible patients.
Is Wegovy the same as compounded semaglutide?
No. Wegovy is an FDA-approved finished product manufactured by Novo Nordisk at a specific 2.4 mg dose. Compounded semaglutide is mixed by a licensed compounding pharmacy and is not FDA-approved. Both contain semaglutide as the active ingredient, but they differ in manufacturing standards, regulatory status, and available doses.
Do I need a prior authorisation for Wegovy?
Most commercial insurance plans require prior authorisation for Wegovy. Telehealth providers such as SkinnyRx, Found Health, and Sesame Care offer PA support as part of their service. Without insurance, the Novo Nordisk savings programme (WeGoTogether) may reduce costs for eligible patients.
Can I get Wegovy online without an in-person visit?
Yes. All platforms on this list conduct a clinical evaluation asynchronously or via video, which satisfies the prescribing requirements for Wegovy in most US states. A valid prescription is required; no platform can legally ship Wegovy without one.
- STEP 1 — NEJM 2021 · Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med 2021;384:989–1002.
- SELECT — NEJM 2023 · Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med 2023;389:2221–2232.
RxNotebook is an editorial publication, not a medical practice. We are not affiliated with the cited studies; source material does not endorse the providers shown. This is general information, not medical advice.